Deletion of TRAAK Potassium Channel Affects Brain Metabolism and Protects against Ischemia

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Laigle, Christophe ^a   Confort Gouny, Sylviane ^a   Le Fur, Yann ^a   Cozzone, Patrick J ^a   Viola, Angèle ^a  

^a University of Aix Marseille   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL; TANDEM PORE DOMAIN POTASSIUM CHANNEL; TAURINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN MICROCIRCULATION; BRAIN SIZE; CHANNEL GATING; CONTROLLED STUDY; FEMALE; GENE DELETION; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PH; PHENOTYPE; PROTEIN EXPRESSION;

ANIMALS; BRAIN; CYTOPROTECTION; ENERGY METABOLISM; FEMALE; GENE DELETION; HYPOXIA-ISCHEMIA, BRAIN; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POTASSIUM CHANNELS;

MUS;

EID: 84871677672     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053266     Document Type: Article

References (89)

1. Judge SI, Smith PJ, Stewart PE, Bever CT Jr, (2007) Potassium channel blockers and openers as CNS neurologic therapeutic agents. Recent Patents CNS Drug Discov 2: 200-228.
2. Lesage F, Lazdunski M, (2000) Molecular and functional properties of two-pore-domain potassium channels. Am J Physiol Renal Physiol 279: F793-801.
3. Pasler D, Gabriel S, Heinemann U, (2007) Two-pore-domain potassium channels contribute to neuronal potassium release and glial potassium buffering in the rat hippocampus. Brain Res 1173: 14-26.
4. Lesage F, (2003) Pharmacology of neuronal background potassium channels. Neuropharmacology 44: 1-7.
5. Patel AJ, Honore E, (2001) Properties and modulation of mammalian 2P domain K+ channels. Trends Neurosci 24: 339-346.
6. Franks NP, Honore E, (2004) The TREK K2P channels and their role in general anaesthesia and neuroprotection. Trends Pharmacol Sci 25: 601-608.
7. Maingret F, Fosset M, Lesage F, Lazdunski M, Honore E, (1999) TRAAK is a mammalian neuronal mechano-gated K+ channel. J Biol Chem 274: 1381-1387.
8. Talley EM, Solorzano G, Lei Q, Kim D, Bayliss DA, (2001) Cns distribution of members of the two-pore-domain (KCNK) potassium channel family. J Neurosci 21: 7491-7505.
9. Medhurst AD, Rennie G, Chapman CG, Meadows H, Duckworth MD, et al. (2001) Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery. Brain Res Mol Brain Res 86: 101-114.
10. Bryan RM, You J, Phillips SC, Andresen JJ, Lloyd EE, et al. (2006) Evidence for Two-Pore Domain Potassium Channels in Rat Cerebral Arteries. Am J Physiol Heart Circ Physiol.
11. Noel J, Zimmermann K, Busserolles J, Deval E, Alloui A, et al. (2009) The mechano-activated K+ channels TRAAK and TREK-1 control both warm and cold perception. Embo J 28: 1308-1318.
12. Heurteaux C, Guy N, Laigle C, Blondeau N, Duprat F, et al. (2004) TREK-1, a K+ channel involved in neuroprotection and general anesthesia. Embo J 23: 2684-2695.
13. Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, et al. (2000) Polyunsaturated fatty acids are potent neuroprotectors. Embo J 19: 1784-1793.
14. Kim Y, Bang H, Gnatenco C, Kim D, (2001) Synergistic interaction and the role of C-terminus in the activation of TRAAK K+ channels by pressure, free fatty acids and alkali. Pflugers Arch 442: 64-72.
15. Reyes R, Lauritzen I, Lesage F, Ettaiche M, Fosset M, et al. (2000) Immunolocalization of the arachidonic acid and mechanosensitive baseline traak potassium channel in the nervous system. Neuroscience 95: 893-901.
16. Fink M, Lesage F, Duprat F, Heurteaux C, Reyes R, et al. (1998) A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids. Embo J 17: 3297-3308.
17. Lesage F, Maingret F, Lazdunski M, (2000) Cloning and expression of human TRAAK, a polyunsaturated fatty acids-activated and mechano-sensitive K(+) channel. FEBS Lett 471: 137-140.
18. Maingret F, Patel AJ, Lesage F, Lazdunski M, Honore E, (2000) Lysophospholipids open the two-pore domain mechano-gated K(+) channels TREK-1 and TRAAK. J Biol Chem 275: 10128-10133.
19. Mathie A, (2007) Neuronal two-pore-domain potassium channels and their regulation by G protein-coupled receptors. J Physiol 578: 377-385.
20. Lopes CM, Rohacs T, Czirjak G, Balla T, Enyedi P, et al. (2005) PIP2 hydrolysis underlies agonist-induced inhibition and regulates voltage gating of two-pore domain K+ channels. J Physiol 564: 117-129.
21. Butcher K, Parsons M, Allport L, Lee SB, Barber PA, et al. (2008) Rapid assessment of perfusion-diffusion mismatch. Stroke 39: 75-81.
22. Parsons MW, Li T, Barber PA, Yang Q, Darby DG, et al. (2000) Combined (1)H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome. Neurology 55: 498-505.
23. Nicoli F, Lefur Y, Denis B, Ranjeva JP, Confort-Gouny S, et al. (2003) Metabolic counterpart of decreased apparent diffusion coefficient during hyperacute ischemic stroke: a brain proton magnetic resonance spectroscopic imaging study. Stroke 34: e82-87.
24. Viola A, Saywell V, Villard L, Cozzone PJ, Lutz NW, (2007) Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model. PLoS One 2: e157.
25. Heurteaux C, Laigle C, Blondeau N, Jarretou G, Lazdunski M, (2006) Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience 137: 241-251.
26. Penet MF, Viola A, Confort-Gouny S, Le Fur Y, Duhamel G, et al. (2005) Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. J Neurosci 25: 7352-7358.
27. Tkac I, Starcuk Z, Choi IY, Gruetter R, (1999) In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med 41: 649-656.
28. Viola A, Confort-Gouny S, Schneider JF, Le Fur Y, Viout P, et al. (2011) Is brain maturation comparable in fetuses and premature neonates at term equivalent age? AJNR Am J Neuroradiol 32: 1451-1458.
29. Penet MF, Laigle C, Fur YL, Confort-Gouny S, Heurteaux C, et al. (2006) In vivo characterization of brain morphometric and metabolic endophenotypes in three inbred strains of mice using magnetic resonance techniques. Behav Genet 36: 732-744.
30. Yancey PH, (2005) Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses. J Exp Biol 208: 2819-2830.
31. Saransaari P, Oja SS, (2000) Taurine and neural cell damage. Amino Acids 19: 509-526.
32. Schaffer S, Takahashi K, Azuma J, (2000) Role of osmoregulation in the actions of taurine. Amino Acids 19: 527-546.
33. Bulley S, Liu Y, Ripps H, Shen W, (2012) Taurine Activates Delayed Rectifier KV Channels via a Metabotropic Pathway in Retinal Neurons. J Physiol.
34. Brand A, Leibfritz D, Hamprecht B, Dringen R, (1998) Metabolism of cysteine in astroglial cells: synthesis of hypotaurine and taurine. J Neurochem 71: 827-832.
35. Vitvitsky V, Garg SK, Banerjee R, (2011) Taurine biosynthesis by neurons and astrocytes. J Biol Chem 286: 32002-32010.
36. Pow DV, Sullivan R, Reye P, Hermanussen S, (2002) Localization of taurine transporters, taurine, and (3)H taurine accumulation in the rat retina, pituitary, and brain. Glia 37: 153-168.
37. Urenjak J, Williams SR, Gadian DG, Noble M, (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13: 981-989.
38. Brand A, Richter-Landsberg C, Leibfritz D, (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15: 289-298.
39. Fisher SK, Novak JE, Agranoff BW, (2002) Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem 82: 736-754.
40. Strange K, (2004) Cellular volume homeostasis. Adv Physiol Educ 28: 155-159.
41. Hoffmann EK, Lambert IH, Pedersen SF, (2009) Physiology of cell volume regulation in vertebrates. Physiol Rev 89: 193-277.
42. Lang F, Busch GL, Ritter M, Volkl H, Waldegger S, et al. (1998) Functional significance of cell volume regulatory mechanisms. Physiol Rev 78: 247-306.
43. Lambert IH, Hoffmann EK, Pedersen SF, (2008) Cell volume regulation: physiology and pathophysiology. Acta Physiol (Oxf) 194: 255-282.
44. Beetsch JW, Olson JE, (1998) Taurine synthesis and cysteine metabolism in cultured rat astrocytes: effects of hyperosmotic exposure. Am J Physiol 274: C866-874.
45. Bitoun M, Tappaz M, (2000) Gene expression of the transporters and biosynthetic enzymes of the osmolytes in astrocyte primary cultures exposed to hyperosmotic conditions. Glia 32: 165-176.
46. Olson JE, Martinho E Jr, (2006) Regulation of taurine transport in rat hippocampal neurons by hypo-osmotic swelling. J Neurochem 96: 1375-1389.
47. Cardin V, Pena-Segura C, Pasantes-Morales H, (1999) Activation and inactivation of taurine efflux in hyposmotic and isosmotic swelling in cortical astrocytes: role of ionic strength and cell volume decrease. J Neurosci Res 56: 659-667.
48. Sabbadini M, Yost CS, (2009) Molecular biology of background K channels: insights from K(2P) knockout mice. J Mol Biol 385: 1331-1344.
49. Brand A, Richter-Landsberg C, Leibfritz D, (1997) Metabolism of acetate in rat brain neurons, astrocytes and cocultures: metabolic interactions between neurons and glia cells, monitored by NMR spectroscopy. Cell Mol Biol (Noisy-le-grand) 43: 645-657.
50. Inoue K, Shimada S, Minami Y, Morimura H, Miyai A, et al. (1996) Cellular localization of Na+/MYO-inositol co-transporter mRNA in the rat brain. Neuroreport 7: 1195-1198.
51. Andrews RJ, (1991) Transhemispheric diaschisis. A review and comment. Stroke 22: 943-949.
52. Hayward NM, Yanev P, Haapasalo A, Miettinen R, Hiltunen M, et al. (2011) Chronic hyperperfusion and angiogenesis follow subacute hypoperfusion in the thalamus of rats with focal cerebral ischemia. J Cereb Blood Flow Metab 31: 1119-1132.
53. Liu KF, Li F, Tatlisumak T, Garcia JH, Sotak CH, et al. (2001) Regional variations in the apparent diffusion coefficient and the intracellular distribution of water in rat brain during acute focal ischemia. Stroke 32: 1897-1905.
54. Kimelberg HK, (2005) Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 50: 389-397.
55. Sims NR, Anderson MF, (2002) Mitochondrial contributions to tissue damage in stroke. Neurochem Int 40: 511-526.
56. Rossi DJ, Brady JD, Mohr C, (2007) Astrocyte metabolism and signaling during brain ischemia. Nat Neurosci 10: 1377-1386.
57. Ding D, Moskowitz SI, Li R, Lee SB, Esteban M, et al. (2000) Acidosis induces necrosis and apoptosis of cultured hippocampal neurons. Exp Neurol 162: 1-12.
58. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM, (2007) N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81: 89-131.
59. Berthet C, Lei H, Gruetter R, Hirt L, (2011) Early predictive biomarkers for lesion after transient cerebral ischemia. Stroke 42: 799-805.
60. Cho TH, Hermier M, Alawneh JA, Ritzenthaler T, Desestret V, et al. (2009) Total mismatch: negative diffusion-weighted imaging but extensive perfusion defect in acute stroke. Stroke 40: 3400-3402.
61. Doubal FN, Dennis MS, Wardlaw JM, (2011) Characteristics of patients with minor ischaemic strokes and negative MRI: a cross-sectional study. J Neurol Neurosurg Psychiatry 82: 540-542.
62. Ay H, Buonanno FS, Rordorf G, Schaefer PW, Schwamm LH, et al. (1999) Normal diffusion-weighted MRI during stroke-like deficits. Neurology 52: 1784-1792.
63. Saunders DE, Howe FA, van den Boogaart A, McLean MA, Griffiths JR, et al. (1995) Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke 26: 1007-1013.
64. Hoehn M, Nicolay K, Franke C, van der Sanden B, (2001) Application of magnetic resonance to animal models of cerebral ischemia. J Magn Reson Imaging 14: 491-509.
65. Saransaari P, Oja SS, (1999) Characteristics of ischemia-induced taurine release in the developing mouse hippocampus. Neuroscience 94: 949-954.
66. Rumpel H, Lim WE, Chang HM, Chan LL, Ho GL, et al. (2003) Is myo-inositol a measure of glial swelling after stroke? A magnetic resonance study. J Magn Reson Imaging 17: 11-19.
67. Yamashita T, Kohmura E, Yamauchi A, Shimada S, Yuguchi T, et al. (1996) Induction of Na+/myo-inositol cotransporter mRNA after focal cerebral ischemia: evidence for extensive osmotic stress in remote areas. J Cereb Blood Flow Metab 16: 1203-1210.
68. Saransaari P, Oja SS, (2008) Nitric oxide is involved in taurine release in the mouse brain stem under normal and ischemic conditions. Amino Acids 34: 429-436.
69. Schurr A, Tseng MT, West CA, Rigor BM, (1987) Taurine improves the recovery of neuronal function following cerebral hypoxia: an in vitro study. Life Sci 40: 2059-2066.
70. Sun M, Zhao Y, Xu C, (2008) Cross-talk between calpain and caspase-3 in penumbra and core during focal cerebral ischemia-reperfusion. Cell Mol Neurobiol 28: 71-85.
71. Taranukhin AG, Taranukhina EY, Saransaari P, Djatchkova IM, Pelto-Huikko M, et al. (2008) Taurine reduces caspase-8 and caspase-9 expression induced by ischemia in the mouse hypothalamic nuclei. Amino Acids 34: 169-174.
72. Wang GH, Jiang ZL, Fan XJ, Zhang L, Li X, et al. (2007) Neuroprotective effect of taurine against focal cerebral ischemia in rats possibly mediated by activation of both GABAA and glycine receptors. Neuropharmacology 52: 1199-1209.
73. Molchanova SM, Oja SS, Saransaari P, (2006) Taurine attenuates D-[3H]aspartate release evoked by depolarization in ischemic corticostriatal slices. Brain Res 1099: 64-72.
74. Leon R, Wu H, Jin Y, Wei J, Buddhala C, et al. (2009) Protective function of taurine in glutamate-induced apoptosis in cultured neurons. J Neurosci Res 87: 1185-1194.
75. Moran J, Maar TE, Pasantes-Morales H, (1994) Impaired cell volume regulation in taurine deficient cultured astrocytes. Neurochem Res 19: 415-420.
76. Zhou F, Guo J, Yang R, Gu J, Jin H, et al. (2006) Effects of taurine on cerebral blood flow perfusion, cell apoptosis, and infarct volume in acute cerebral ischemic rats. Adv Exp Med Biol 583: 353-358.
77. Sun M, Gu Y, Zhao Y, Xu C, (2011) Protective functions of taurine against experimental stroke through depressing mitochondria-mediated cell death in rats. Amino Acids 40: 1419-1429.
78. Chvatal A, Anderova M, Kirchhoff F, (2007) Three-dimensional confocal morphometry- a new approach for studying dynamic changes in cell morphology in brain slices. J Anat 210: 671-683.
79. Won SJ, Kim DY, Gwag BJ, (2002) Cellular and molecular pathways of ischemic neuronal death. J Biochem Mol Biol 35: 67-86.
80. Meadows HJ, Chapman CG, Duckworth DM, Kelsell RE, Murdock PR, et al. (2001) The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K(+) channels TREK-1 and TRAAK. Brain Res 892: 94-101.
81. Ahn HS, Choi JS, Choi BH, Kim MJ, Rhie DJ, et al. (2005) Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole. Neuroscience 133: 1007-1019.
82. Huang CS, Song JH, Nagata K, Yeh JZ, Narahashi T, (1997) Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons. J Pharmacol Exp Ther 282: 1280-1290.
83. Stefani A, Spadoni F, Bernardi G, (1997) Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: implications for neuroprotective strategies. Exp Neurol 147: 115-122.
84. Urbani A, Belluzzi O, (2000) Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur J Neurosci 12: 3567-3574.
85. Ren L, Fang Y, Zhang A, Li X, Wang X, et al. (2010) Effect of electroacupuncture on the expression of Nav1.1 in rat after acute cerebral ischemia. Neurol Res 32: 763-769.
86. Kang JX, Leaf A, (1996) Evidence that free polyunsaturated fatty acids modify Na+ channels by directly binding to the channel proteins. Proc Natl Acad Sci U S A 93: 3542-3546.
87. Smith SE, Lekieffre D, Sowinski P, Meldrum BS, (1993) Cerebroprotective effect of BW619C89 after focal or global cerebral ischaemia in the rat. Neuroreport 4: 1339-1342.
88. McNaughton NC, Hainsworth AH, Green PJ, Randall AD, (2000) Inhibition of recombinant low-voltage-activated Ca(2+) channels by the neuroprotective agent BW619C89 (Sipatrigine). Neuropharmacology 39: 1247-1253.
89. Mathie A, Veale EL, (2007) Therapeutic potential of neuronal two-pore domain potassium-channel modulators. Curr Opin Investig Drugs 8: 555-562.